Getting serious about biosimilars

1 December 2015 0

As patents on the first generation of monoclonal antibodies begin to expire, the cancer community will need to get to grips with the unique issues involved in ensuring the safety and efficacy of copies of [more]

They are many, will we be too few?

1 May 2015 0

The European Commission is predicting that by 2020 Europe will need an additional one million clinical professionals to care for its ageing population. With many of our cancer systems already working at full capacity, this [more]

UA-77507851-1